NCT05435170View on ClinicalTrials.gov

Food Effect Study of Linerixibat Tablets in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions

Pruritus

Interventions

DRUG

linerixibat

linerixibat will be administered per the treatment sequence

Trial Locations (1)

CB2 0GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY